Physician profile

Yaron Raducanu

Podiatrist · Galloway, NJ

NPI 1134117625

$6,783.23

in general payments reported to CMS, 2019-2025

37 companies · $3,920 in 2025

The $3,920 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,417.84
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$3,000.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Biopoly LLC $3,000.00 2025 Biopoly Great Toe Hemiarthroplasty Implant
Abbvie INC. $385.35 2022-2024
Averitas Pharma INC. $360.78 2023-2025 Qutenza
Stryker Corporation $334.55 2023-2025 Prostep Mica, Augment Injectable, Citrefix
Eclipse Technology Solutions INC. $281.20 2023-2025
Paratek Pharmaceuticals, INC. $197.83 2023-2025 Nuzyra
Globus Medical, INC. $190.08 2023-2024 Precice Intramedullary Limb Lengthening System, Ankle Fracture System
Vaporox, INC. $166.87 2023 Vht-200 Wound Treatment System
Smith+Nephew, INC. $156.15 2023-2025 Pico 7, Stravix Mesh, Renasys Go V2 Home
Treace Medical Concepts, INC. $142.55 2023-2024
Medshape, INC. $135.22 2023 Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Hybrid
Bard Peripheral Vascular, INC. $132.44 2024
Acell, INC. $121.49 2019
Restor3d, INC. $119.48 2024
Medtronic, INC. $117.33 2024 Intellis Adaptivestim
Show all 37 companies
CompanyGeneral paymentsYearsTop products
Paragon 28, INC. $114.12 2024 Portfolio
Next Science LLC $102.22 2023 Surgx, Blastx, Xperience
Depuy Synthes Sales INC. $98.72 2019-2024 Motoband, Minibunion, Dynacord
Amgen INC. $78.89 2024-2025 Krystexxa
Medartis INC. $64.93 2019
Kerecis Limited $61.71 2023-2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide
Convatec INC. $59.96 2025
Arjo INC. $56.52 2024
Mimedx Group, INC. $43.30 2025
Relja Innovations INC $40.29 2023
Reapplix INC. $32.26 2024 3c Patch Kit - Box
Kowa Pharmaceuticals America, INC. $29.42 2023 Seglentis
Tactile Systems Technology INC $22.03 2025 Nimbl, Flexitouch Plus
Reprise Biomedical, INC. $19.50 2025 Miro3d
Orthofix Medical, INC. $18.82 2024 Physio-Stim
Anika Therapeutics, INC. $15.70 2021
Integra Lifesciences Corporation $15.40 2020
Stimlabs LLC $15.40 2025 Corplex P
Ibsa Pharma INC. $14.76 2023 Tirosint, Licart
Solventum Corporation $14.72 2025 Prevena, V.A.C. Veraflo
Advanced Oxygen Therapy INC. $11.94 2025 Topical Oxygen Chamber For Extremities
Arthrosurface Incorporated $11.30 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Yaron Raducanu

$6,783.23

in general payments reported 2019-2025

Years
2019-2025
Top company
Biopoly LLC
Context
The $3,920 reported for 2025 was more than what 95% of Podiatrist providers received nationally (typical 2025 total: $260).

https://glasscript.com/doctor/822341/yaron-raducanu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.